02.02.2017 Views

Animal Antibiotics and Antimicrobials Market - Global Forecast to 2021

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market is mainly attributed to rising demand for animal-derived food products, growing demand for pet insurance and rising animal health expenditure, and increasing incidences of zoonotic diseases.

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market is mainly attributed to rising demand for animal-derived food products, growing demand for pet insurance and rising animal health expenditure, and increasing incidences of zoonotic diseases.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Animal</strong> <strong>Antibiotics</strong> <strong>and</strong> <strong>Antimicrobials</strong> <strong>Market</strong> by Product<br />

(Tetracycline, Penicillin, Sulfonamide, Macrolide,<br />

Cephalosporin, Fluoroquinolone), Mode of Delivery<br />

(Premixes, Oral Powder, Injection), <strong>Animal</strong> (Food-producing<br />

& Companion) - <strong>Global</strong> <strong>Forecast</strong> <strong>to</strong> <strong>2021</strong><br />

Published On : December 2016<br />

Category : Pharmaceuticals<br />

Pages : 210 pages<br />

Contact : International : (+1) 646 781 7170 help@gr<strong>and</strong>researchs<strong>to</strong>re.com<br />

Report Description:<br />

The global animal antibiotics <strong>and</strong> antimicrobials market is estimated <strong>to</strong> grow at a CAGR of<br />

4.6% from 2016 <strong>to</strong> <strong>2021</strong>, <strong>to</strong> reach USD 4.73 billion by <strong>2021</strong> from USD 3.77 billion in 2016.<br />

The growth of this market is mainly attributed <strong>to</strong> rising dem<strong>and</strong> for animal-derived food<br />

products, growing dem<strong>and</strong> for pet insurance <strong>and</strong> rising animal health expenditure, <strong>and</strong><br />

increasing incidences of zoonotic diseases. In addition, the implementation of the<br />

regulations for preventing the spread of animal diseases <strong>and</strong> increasing awareness about<br />

animal healthcare are further expected <strong>to</strong> drive the growth of this market. However,<br />

growing resistance <strong>to</strong> the antibiotic <strong>and</strong> antimicrobial agents, dearth of new antibiotics, <strong>and</strong><br />

replacement of routine prophylactic use of antibiotics by good husb<strong>and</strong>ry <strong>and</strong> hygiene<br />

practices may hinder the growth of this market <strong>to</strong> certain extent. Untapped emerging<br />

market such as China, India offers significant growth opportunities.<br />

Based on the type of product, the animal antibiotics <strong>and</strong> antimicrobials market is segmented<br />

in<strong>to</strong> tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones,<br />

lincosamides, cephalosporins, <strong>and</strong> other antimicrobials <strong>and</strong> antibiotics. On the basis of mode<br />

of delivery, the market is further segmented in<strong>to</strong> premixes, oral powders, oral solutions,


injections, <strong>and</strong> other modes of delivery. Similarly, on the basis of type of animals the animal<br />

antibiotics <strong>and</strong> antimicrobials market is segmented in<strong>to</strong> food-producing animals <strong>and</strong><br />

companion animals. The food-producing animals segment accounted for the largest share of<br />

the animal antibiotics <strong>and</strong> antimicrobials market in 2015.<br />

Geographically, the global animal antibiotics <strong>and</strong> antimicrobials market is segmented in<strong>to</strong><br />

North America, Europe, Asia-Pacific, <strong>and</strong> the Rest of the World. In 2015, North America<br />

comm<strong>and</strong>ed a major share of the animal antibiotics <strong>and</strong> antimicrobials market. This is<br />

mainly due <strong>to</strong> the increasing adoption of companion animals, growing pet insurance<br />

industry, increasing dem<strong>and</strong> for animal-derived food products, <strong>and</strong> rising veterinary<br />

healthcare expenditure in the region. However, Asia-Pacific is expected <strong>to</strong> witness the<br />

highest growth rate during the forecast period. Growth in the Asia-Pacific market can be<br />

attributed <strong>to</strong> rising companion animal population <strong>and</strong> increase in the dem<strong>and</strong> for animalderived<br />

food products.<br />

Some of the prominent players in the animal antibiotics <strong>and</strong> antimicrobials market include<br />

Zoetis, Inc. (U.S.), Eli Lilly <strong>and</strong> Company (U.S.), Merck & Co., Inc. (U.S.), Bayer AG<br />

(Germany), Boehringer Ingelheim GmbH (Germany), Virbac (France), Ceva Sante <strong>Animal</strong>e<br />

(France), Ve<strong>to</strong>quinol S.A. (France), <strong>and</strong> Dechra Pharmaceuticals PLC (U.K.)<br />

Research Coverage:<br />

In addition <strong>to</strong> deep down segmentation provided in this report, it briefs about the market<br />

dynamics including drivers, restraints, opportunities, challenges, <strong>and</strong> market trends. The<br />

report also covers the regula<strong>to</strong>ry analysis for the production <strong>and</strong> marketing of the animal<br />

antibiotic <strong>and</strong> antimicrobial products. In addition, this report highlights the growth<br />

strategies adopted by the major market players <strong>to</strong> garner larger share in the animal<br />

antibiotics <strong>and</strong> antimicrobials market.<br />

Reasons <strong>to</strong> Buy the Report:<br />

The report will enrich both established firms as well as new entrants/smaller firms <strong>to</strong> gauge<br />

the pulse of the market, which in turn will help firms in garnering a greater market share.<br />

Firms purchasing the report could use any one or combination of the below-mentioned five<br />

strategies (market penetration, product development/innovation, market development,<br />

market diversification, <strong>and</strong> competitive assessment) for increasing their market shares.<br />

The report provides insights on the following pointers:<br />

? <strong>Market</strong> Penetration: Comprehensive information on the product portfolios offered by the<br />

<strong>to</strong>p players in the animal antibiotics <strong>and</strong> antimicrobials market. The report analyzes the<br />

animal antibiotic <strong>and</strong> antimicrobial agents market by product, mode of delivery, animal type,<br />

<strong>and</strong> region<br />

? Product Development/Innovation: Detailed insights on the upcoming trends, research <strong>and</strong><br />

development activities, <strong>and</strong> new product launches in the animal antibiotics <strong>and</strong><br />

antimicrobials market<br />

? <strong>Market</strong> Development: Comprehensive information about lucrative emerging markets by<br />

product <strong>and</strong> region<br />

? <strong>Market</strong> Diversification: Exhaustive information about new products, growing geographies,<br />

recent developments, <strong>and</strong> investments in the animal antibiotics <strong>and</strong> antimicrobials market<br />

? Competitive Assessment: In-depth assessment of market shares, growth strategies,<br />

products, <strong>and</strong> manufacturing capabilities of leading players in the animal antibiotics <strong>and</strong>


antimicrobials market<br />

Table of contents:<br />

TABLE OF CONTENTS<br />

1 INTRODUCTION 17<br />

1.1 OBJECTIVES OF THE STUDY 17<br />

1.2 MARKET DEFINITION 17<br />

1.3 MARKET SCOPE 18<br />

1.3.1 MARKETS COVERED 18<br />

1.3.2 REGIONAL SCOPE 19<br />

1.3.3 YEARS CONSIDERED FOR THE STUDY 19<br />

1.4 CURRENCY & PRICING 20<br />

1.5 STUDY LIMITATIONS 20<br />

1.6 MARKET STAKEHOLDERS 20<br />

2 RESEARCH METHODOLOGY 21<br />

2.1 RESEARCH DATA 21<br />

2.1.1 SECONDARY DATA 23<br />

2.1.1.1 Key data from secondary sources 23<br />

2.1.2 PRIMARY DATA 24<br />

2.1.2.1 Key data from primary sources 24<br />

2.1.2.2 Breakdown of primaries 25<br />

2.2 MARKET SIZE ESTIMATION 25<br />

2.2.1 BOTTOM-UP APPROACH 26<br />

2.2.2 TOP-DOWN APPROACH 27<br />

2.3 MARKET BREAKDOWN & DATA TRIANGULATION 28<br />

2.4 RESEARCH ASSUMPTIONS 29<br />

3 EXECUTIVE SUMMARY 30<br />

4 PREMIUM INSIGHTS 35<br />

4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE MILITARY ELECTRO-<br />

OPTICS/INFRARED SYSTEMS MARKET 35<br />

4.2 AIR BASED PLATFORM ESTIMATED TO LEAD THE MILITARY ELECTRO-<br />

OPTICS/INFRARED SYSTEMS MARKET IN 2016 36<br />

4.3 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY SYSTEM 36<br />

4.4 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY SENSOR<br />

TECHNOLOGY, 2016 37<br />

4.5 LIFE CYCLE ANALYSIS, BY REGION 37<br />

5 MARKET OVERVIEW 38<br />

5.1 INTRODUCTION 38


5.2 MARKET SEGMENTATION 38<br />

5.2.1 BY PLATFORM 38<br />

5.2.2 BY SYSTEM 39<br />

5.2.3 BY TECHNOLOGY 39<br />

5.2.4 BY IMAGING TECHNOLOGY 40<br />

5.2.5 BY SENSOR TECHNOLOGY 41<br />

5.2.6 BY WAVELENGTH 41<br />

5.3 MARKET DYNAMICS 42<br />

5.3.1 DRIVERS 43<br />

5.3.1.1 Increased dem<strong>and</strong> for battlespace awareness by defense forces 43<br />

5.3.1.2 Technological advancements resulting in improved efficiency of EO/IR systems 43<br />

5.3.1.3 Increased deployment of electro-optics/infrared systems for unmanned vehicles 44<br />

5.3.2 RESTRAINTS 45<br />

5.3.2.1 Stagnant product life cycle 45<br />

5.3.3 OPPORTUNITIES 45<br />

5.3.3.1 Proliferation of aerostats 45<br />

5.3.3.2 Development of electro-optics/infrared systems <strong>to</strong> synchronize with conventional<br />

military systems 46<br />

5.3.4 CHALLENGES 46<br />

5.3.4.1 Inefficient performance in extreme weather conditions 46<br />

5.3.4.2 Designing efficient <strong>and</strong> cost-effective target locking system for military aircraft 47<br />

6 INDUSTRY TRENDS 48<br />

6.1 INTRODUCTION 48<br />

6.2 TECHNOLOGY TRENDS 49<br />

6.2.1 ARMY 3RD GEN FLIR 49<br />

6.2.2 PERSISTENT SURVEILLANCE SYSTEMS 50<br />

6.2.3 MULTISPECTRAL AND HYPERSPECTRAL SENSORS 50<br />

6.2.4 ADVANCED 3D VISUALIZATION 51<br />

6.2.5 MULTI-SENSOR TECHNOLOGY 51<br />

6.2.6 MICROBOLOMETER 51<br />

6.2.7 III–V SUPERLATTICE 52<br />

6.2.8 SYNTHETIC APERTURE RADARS 52<br />

6.2.9 COOLED THERMAL CAMERAS 52<br />

6.3 PROSPECTIVE TECHNOLOGIES 53<br />

6.4 SUPPLY CHAIN ANALYSIS 54<br />

7 MILITARY ELECTRO-OPTICS/ INFRARED SYSTEMS MARKET, BY PLATFORM 56<br />

7.1 INTRODUCTION 57<br />

7.2 AIR 58<br />

7.3 NAVAL 59<br />

7.4 LAND 60<br />

8 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY SYSTEM 61<br />

8.1 INTRODUCTION 62<br />

8.2 TARGETING SYSTEM 63<br />

8.3 ELECTRONIC SUPPORT MEASURE (ESM) 64


8.4 IMAGING SYSTEM 65<br />

9 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY TECHNOLOGY 66<br />

9.1 INTRODUCTION 67<br />

9.2 COOLED 68<br />

9.3 UNCOOLED 69<br />

10 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY SENSOR<br />

TECHNOLOGY 70<br />

10.1 INTRODUCTION 71<br />

10.2 STARING SENSOR 72<br />

10.3 SCANNING SENSOR 73<br />

11 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY IMAGING<br />

TECHNOLOGY 74<br />

11.1 INTRODUCTION 75<br />

11.2 MULTISPECTRAL 76<br />

11.3 HYPERSPECTRAL 77<br />

12 MILITARY ELECTRO-OPTICS/INFRARED SYSTEMS MARKET, BY WAVELENGTH 78<br />

12.1 INTRODUCTION 79<br />

12.2 ULTRAVIOLET 80<br />

12.3 NEAR INFRARED 80<br />

12.4 SHORT WAVELENGTH INFRARED 80<br />

12.5 MEDIUM WAVELENGTH INFRARED 81<br />

12.6 LONG WAVELENGTH INFRARED 81<br />

13 REGIONAL ANALYSIS 82<br />

13.1 INTRODUCTION 83<br />

13.2 NORTH AMERICA 85<br />

13.2.1 BY PLATFORM 87<br />

13.2.2 BY SYSTEM 87<br />

13.2.3 BY TECHNOLOGY 87<br />

13.2.4 BY SENSOR TECHNOLOGY 88<br />

13.2.5 BY IMAGING TECHNOLOGY 88<br />

13.2.6 BY COUNTRY 88<br />

13.2.6.1 U.S. 89<br />

13.2.6.1.1 By platform 89<br />

13.2.6.1.2 By system 90<br />

13.2.6.2 Canada 90<br />

13.2.6.2.1 By platform 90<br />

13.2.6.2.2 By system 91<br />

13.3 EUROPE 91<br />

13.3.1 BY PLATFORM 93<br />

13.3.2 BY SYSTEM 93<br />

13.3.3 BY TECHNOLOGY 94<br />

13.3.4 BY SENSOR TECHNOLOGY 94<br />

13.3.5 BY IMAGING TECHNOLOGY 94


13.3.6 BY COUNTRY 95<br />

13.3.6.1 Russia 95<br />

13.3.6.1.1 By platform 95<br />

13.3.6.1.2 By system 96<br />

13.3.6.2 France 96<br />

13.3.6.2.1 By platform 97<br />

13.3.6.2.2 By system 97<br />

13.3.6.3 Germany 97<br />

13.3.6.3.1 By platform 98<br />

13.3.6.3.2 By system 98<br />

13.3.6.4 U.K. 99<br />

13.3.6.4.1 By platform 99<br />

13.3.6.4.2 By system, 100<br />

13.3.6.5 Rest of Europe 100<br />

13.3.6.5.1 By platform, 100<br />

13.3.6.5.2 By system 101<br />

13.4 ASIA-PACIFIC 101<br />

13.4.1 BY PLATFORM 103<br />

13.4.2 BY SYSTEM 103<br />

13.4.3 BY TECHNOLOGY 103<br />

13.4.4 BY SENSOR TECHNOLOGY 104<br />

13.4.5 BY IMAGING TECHNOLOGY 104<br />

13.4.6 BY COUNTRY 105<br />

13.4.6.1 China 105<br />

13.4.6.1.1 By platform 106<br />

13.4.6.1.2 By system 106<br />

13.4.6.2 Japan 106<br />

13.4.6.2.1 By platform 107<br />

13.4.6.2.2 By system 107<br />

13.4.6.3 India 107<br />

13.4.6.3.1 By platform 108<br />

13.4.6.3.2 By system 108<br />

13.4.6.4 Australia 108<br />

13.4.6.4.1 By platform 109<br />

13.4.6.4.2 By system 109<br />

13.4.6.5 Rest of Asia-Pacific 110<br />

13.4.6.5.1 By platform 110<br />

13.4.6.5.2 By system 110<br />

13.5 THE MIDDLE EAST 111<br />

13.5.1 BY PLATFORM 113<br />

13.5.2 BY SYSTEM 113<br />

13.5.3 BY TECHNOLOGY 114<br />

13.5.4 BY SENSOR TECHNOLOGY 114<br />

13.5.5 BY IMAGING TECHNOLOGY 114


13.5.6 BY COUNTRY 115<br />

13.5.6.1 Saudi Arabia 115<br />

13.5.6.1.1 By platform 116<br />

13.5.6.1.2 By system 116<br />

13.5.6.2 Israel 116<br />

13.5.6.2.1 By platform 117<br />

13.5.6.2.2 By system 117<br />

13.5.6.3 Rest of the Middle East 118<br />

13.5.6.3.1 By platform 118<br />

13.5.6.3.2 By system 118<br />

13.6 REST OF THE WORLD 119<br />

13.6.1 BY PLATFORM 119<br />

13.6.2 BY SYSTEM 120<br />

13.6.3 BY TECHNOLOGY 120<br />

13.6.4 BY SENSOR TECHNOLOGY 121<br />

13.6.5 BY IMAGING TECHNOLOGY 121<br />

14 COMPETITIVE LANDSCAPE 122<br />

14.1 INTRODUCTION 122<br />

14.2 COMPETITIVE ANALYSIS 123<br />

14.3 MARKET RANKING ANALYSIS 125<br />

14.4 BRAND ANALYSIS 126<br />

14.5 COMPETITIVE SITUATION & TRENDS 127<br />

14.5.1 CONTRACTS 129<br />

14.5.2 NEW PRODUCT LAUNCHES 132<br />

14.5.3 MERGERS & ACQUISITIONS 133<br />

14.5.4 AGREEMENTS & PARTNERSHIPS 133<br />

15 COMPANY PROFILES 135<br />

15.1 INTRODUCTION 135<br />

(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT<br />

Analysis, Ratio Analysis, MnM View)*<br />

15.2 FINANCIAL HIGHLIGHTS 136<br />

15.3 LOCKHEED MARTIN CORPORATION 137<br />

15.4 NORTHROP GRUMMAN CORPORATION 140<br />

15.5 THE RAYTHEON COMPANY 143<br />

15.6 BAE SYSTEMS PLC. 146<br />

15.7 THALES GROUP 149<br />

15.8 ELBIT SYSTEMS LTD. 151<br />

15.9 L-3 COMMUNICATIONS HOLDINGS, INC. 153<br />

15.10 SAAB GROUP 155<br />

15.11 ROCKWELL COLLINS, INC. 157<br />

15.12 RHEINMETALL AG 159<br />

15.13 TEXTRON INC. 162<br />

15.14 ISRAEL AEROSPACE INDUSTRIES 164<br />

*Details on Business Overview, Products & Services, Key Insights, Recent Developments,


SWOT Analysis, MnM View might not be captured in case of unlisted companies.<br />

16 APPENDIX 166<br />

16.1 DISCUSSION GUIDE 166<br />

16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 169<br />

16.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 171<br />

16.4 AVAILABLE CUSTOMIZATIONS 173<br />

16.5 RELATED REPORTS 174<br />

16.6 AUTHOR DETAILS 175<br />

Get full report details at:<br />

https://www.gr<strong>and</strong>researchs<strong>to</strong>re.com/pharmaceuticals/animal-antibiotics-<strong>and</strong>antimicrobials-market-by-product-tetracycline-penicillin-sulfonamidemacrolide-cephalosporin-fluoroquinolone-mode-of-delivery-premixes-oralpowder-injection-animal-food-producing-26-companion---global-forecast<strong>to</strong>-<strong>2021</strong>-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!